2012 annual financial data
Nektar Therapeutics - Common Stock 2012 Operating margin
Nektar Therapeutics - Common Stock 2012 operating margin with verified reported…
Direct answer
Operating margin was -173.91%.
Operating income was -141,201,000 USD and net income was -171,855,000 USD.
Operating cash flow was -129,756,000 USD.
Get free Nektar Therapeutics - Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 81,191,000 USD
- Operating income
- -141,201,000 USD
- Net income
- -171,855,000 USD
- Operating cash flow
- -129,756,000 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Nektar Therapeutics - Common Stock financial years